Galician Study of Heart Failure in Primary Care (GALICAP Study)

Otero-Raviña, Fernando; Grigorian-Shamagian, Lilián; Fransi-Galiana, Luis; Názara-Otero, Carlos; Fernández-Villaverde, José M.; Alamo‐Alonso, Alberto del; Nieto-Pol, Enrique; Santiago-Boullón, Miguel de; López-Rodríguez, Isidro; Cardona-Vidal, José M; Varela-Román, Alfonso; González-Juanàtey, José Ramón

doi:10.1016/s1885-5857(07)60170-4

Cited by 21 publications

(12 citation statements)

References 48 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In the IBERICAN study, as has been repeatedly described [ 26 ], CHF increased with age, in line with what has been confirmed in PC Spanish population [ 4 , 5 , 18 ] and in European studies [ 24 , 25 , 27 ]. In our study, the prevalence reached 15.2% of patients over the age of 80.…”

Section: Discussionsupporting

confidence: 87%

“…Additionally, the registers on CHF carried out in Spain offer relevant information on the clinical characteristics of these patients in our setting. In primary care (PC) [ 4 , 5 ], patients with preserved ejection fraction (pEF) are more frequent, more associated with older women with a history of arterial hypertension (AH), whereas in cardiology departments [ 6 ], it is more common in middle-aged men with reduced EF (rEF) caused by ischemic heart disease (IHD).…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Prevalence of Chronic Heart Failure, Associated Factors, and Therapeutic Management in Primary Care Patients in Spain, IBERICAN Study

Llisterri-Caro

Cinza‐Sanjurjo²,

Martín-Sánchez

et al. 2021

JCM

View full text Add to dashboard Cite

Background: The prevalence of chronic heart failure (CHF) in patients assisted in primary care is not well known. We investigated the prevalence of CHF, its associated factors, and its therapeutic management. Methods and findings: This was a cross-sectional, multicenter study conducted in primary care (PC) in baseline patients of the IBERICAN study (Identification of the Spanish Population at Cardiovascular and Renal Risk). CHF was defined as the presence of this condition in the medical history, classifying patients according to the type of ventricular dysfunction in CHF with preserved ejection fraction (pEF), or CHF with reduced ejection fraction (rEF). Clinical characteristics, relationship between CHF and main cardiovascular risk factors (CVRF), and drug treatments used according to ejection fraction (EF) were analyzed. Results: A total of 8066 patients were included (54.5% women), average age (SD) was 57.9 (14.8) years, of which 3.1% (95% CI: 2.3–3.7) presented CHF, without differences between men and women. CHF with pEF (61.8%; 95% CI: 55.5–67.6) was more frequent in women, and CHF with rEF (38.1%; 95% CI: 33.2–45.5) (p = 0.028) was similar in both genders (65.9%; 95% CI: 57.1–73.4 vs. 57.3%; 95% CI: 47.7–65.8) (p = 0.188). A progressive increase of the prevalence with age (15.2% in ≥80 years) and with the aggregation of CVRF was observed. The most prescribed treatments were beta-blockers (54.7%) followed by angiotensin converting enzyme inhibitors (42.8%) and angiotensin II receptor antagonists (41.3%), without differences between pEF and rEF. The variables that are most associated with the probability of suffering CHF were a personal history of left ventricular hypertrophy (OR: 5.968; p < 0.001), of atrial fibrillation (OR: 3.494; p < 0.001), and of peripheral vascular disease (OR: 2.029; p < 0.001). Conclusions: Three in every 100 patients included in the IBERICAN study presented CHF, of which two thirds had pEF. The condition increased exponentially with age and aggregation of CVRF. We did not find any differences in drug treatment according to the type of ventricular dysfunction. The treatment of HF with rEF has much room for improvement.

show abstract

Section: Discussionsupporting

confidence: 87%

Section: Introductionmentioning

confidence: 99%

Prevalence of Chronic Heart Failure, Associated Factors, and Therapeutic Management in Primary Care Patients in Spain, IBERICAN Study

Llisterri-Caro

Cinza‐Sanjurjo²,

Martín-Sánchez

et al. 2021

JCM

View full text Add to dashboard Cite

show abstract

“…La prevalencia global obtenida de 1% en mayores de 15 años es menor que la detectada en otros estudios realizados en AP 15,16 en los que la inclusión de los pacientes se ha hecho de forma consecutiva de entre los que acudieron a las consultas, mientras que los datos del presente estudio son de registro en base poblacional.…”

Section: Discussionunclassified

“…En cuanto a patología asociada y por sexos, los resultados coinciden con la literatura 20,[21][22][23][24] en la mayor presencia de HTA en mujeres y menor de CI, tabaquismo y asma/EPOC pero no en cuanto a la de DM2, FA, IR, DL, donde existen resultados discordantes posiblemente por que, en la mayoría de ellos, los pacientes proceden de ingresos hospitalarios o de unidades multidisciplinarias ubicadas en hospitales. Nuestros resultados se aproximan más a los del estudio GALICAP 15 que también está realizado en AP.…”

Section: Discussionunclassified

Pacientes con el diagnóstico de insuficiencia cardiaca en Atención Primaria: envejecimiento, comorbilidad y polifarmacia

et al. 2011

View full text Add to dashboard Cite

show abstract

“…21 Only ischemic heart failure was considered, and the proportion of heart failure cases with ischemic etiology was obtained from the GALICAP study conducted in a representative sample of Galicia (northern Spain) (36.8% in men and 26.6% in women). 22 From the same study, we obtained information concerning the severity of heart failure, classified according to New York Heart Association functional class. 23 The disability weight for ischemic heart failure is the weighted average of mild, moderate and severe specific disability weights.…”

Section: Heart Failurementioning

confidence: 99%

Disability-adjusted life years lost due to ischemic heart disease in mainland Portugal, 2013

Henriques

Araújo

Viana

et al. 2017

Revista Portuguesa de Cardiologia (English Edition)

View full text Add to dashboard Cite

Introduction and Objectives:Estimates of the burden of ischemic heart disease (IHD), including geographic differences, should support health policy decisions. We set out to estimate the burden of IHD in mainland Portugal in 2013 by calculating disability-adjusted life years (DALYs) and to compare this burden between five regions. Methods: Years of life lost (YLLs) were calculated by multiplying the number of IHD deaths in 2013 (Statistics Portugal) by the life expectancy at the age at which death occurred. Years lived with disability (YLDs) were computed as the number of cases of acute coronary syndrome, stable angina and ischemic heart failure multiplied by an average disability weight. Crude and age-standardized DALYs (direct method, Standard European Population) were calculated for mainland Portugal and for the Northern, Central, Lisbon, Alentejo and Algarve regions. Results: In 2013, 95 413 DALYs were lost in mainland Portugal due to IHD. YLLs accounted for 88.3% of the disease burden. Age-standardized DALY rates per 1000 population were higher in men than in women, across the entire country (8.9 in men; 3.4 in women) and within each region, ranging from 7.3 in the Northern and Central regions to 11.8 in the Algarve in men, and from 2.6 in the Northern region to 4.6 in Lisbon in women. Conclusions: Nearly 100 000 DALYs were lost to IHD in Portugal, mostly through early mortality. This study enables accurate comparisons with other countries and between regions; however, it highlights the need for population-based studies to obtain specific data on morbidity. PALAVRAS-CHAVEAnos de vida saudável perdidos; Doença isquémica do coração; Portugal Anos de vida saudável perdidos devido a doença isquémica do coração em Portugal continental em 2013Resumo Introdução e objetivos: A carga de doença atribuível à doença isquémica do coração (DIC), nomeadamente possíveis diferenças regionais, deve orientar políticas de saúde. Pretendemos estimar a carga de doença atribuível a DIC em Portugal continental em 2013, através do cálculo dos anos de vida saudável perdidos (DALY) e comparar estas estimativas entre regiões. Métodos: Calcularam-se os anos de vida perdidos (YLL) multiplicando o número de mortes por DIC em 2013 (Instituto Nacional de Estatística) pela esperança média de vida à idade da morte. Estimaram-se os anos vividos com incapacidade (YLD) através do número de casos de síndrome coronária aguda, angina estável e insuficiência cardíaca isquémica. Os DALY brutos e padronizados para a idade (método direto, população-padrão europeia) foram calculados para Portugal continental e para as regiões Norte, Centro, Lisboa, Alentejo e Algarve. Resultados: Em 2013, perderam-se 95 413 DALY em Portugal por DIC. Destes, 88,3% foram por morte prematura. A taxa de DALY perdidos por 1000 habitantes padronizada para a idade foi mais elevada nos homens em todo o país (8,9 nos homens; 3,4 nas mulheres) e em cada região, variando de 7,3 no Norte e Centro até 11,8 no Algarve nos homens, e de 2,6 no Norte a 4,6 em Lisboa nas mul...

show abstract

Galician Study of Heart Failure in Primary Care (GALICAP Study)

Cited by 21 publications

References 48 publications

Prevalence of Chronic Heart Failure, Associated Factors, and Therapeutic Management in Primary Care Patients in Spain, IBERICAN Study

Prevalence of Chronic Heart Failure, Associated Factors, and Therapeutic Management in Primary Care Patients in Spain, IBERICAN Study

Pacientes con el diagnóstico de insuficiencia cardiaca en Atención Primaria: envejecimiento, comorbilidad y polifarmacia

Disability-adjusted life years lost due to ischemic heart disease in mainland Portugal, 2013

Contact Info

Product

Resources

About